Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Authors:

Abstract
No abstract available
Funding Information
  • Genentech
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (RP150535)
  • Merck
  • Bayer HealthCare
  • Novartis
  • University of Texas MD Anderson Cancer Center (P30 CA016672)
  • Pfizer
  • Bayer Corporation
  • AstraZeneca
  • Takeda Pharmaceutical Company
  • Mayo Clinic
  • Spectrum Pharmaceuticals
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Eli Lilly and Company
  • Daiichi Sankyo Company
  • Roche
  • National Institutes of Health
  • Samsung
  • National Cancer Institute (R01CA169338, R01CA204302, R01CA211052, U01CA217882, U54CA224081)
  • North Carolina GlaxoSmithKline Foundation

This publication has 50 references indexed in Scilit: